Fluzone High Dose Northern Hemisphere Injection, Suspension
Product Images NDC 63552-722

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Fluzone High Dose Northern Hemisphere (NDC 63552-722). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Patheon Manufacturing Services Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fluzone (Fluzone Label 49281 125 65)

This is a description of a flu vaccine called Fluzone High-Dose for the 2025-2026 season. It is for intramuscular use and comes in 10 single-dose pre-filled syringes of 0.5 mL each. It is important to store it between 2° to 8°C (35° to 46°F) and to shake it well before use. The vaccine is prepared from influenza viruses propagated in chicken eggs and inactivated with formaldehyde. It contains no preservatives or natural rubber latex. The vaccine is standardized to contain 180 micrograms (mcg) hemagglutinin (HA) per 0.5 mL dose. It is formulated with specific prototype strains for the season, and it is manufactured by Sanofi Pasteur Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.